Endovascular treatment of the patient with vascular type of Ehlers–Danlos syndrome with bilateral dissection stenoses and aneurysms in V3- andV4- segments of vertebral arteries

  • Yu.V. Cherednychenko Dnipropetrovsk Regional Clinical Hospital named after I.I. Mechnikov
  • A.Yu. Miroshnychenko Dnipropetrovsk Regional Clinical Hospital named after I.I. Mechnikov
  • L.A. Dzyak Dnipropetrovsk Medical Academy
  • N.A. Zorin Dnipropetrovsk Medical Academy
  • S.P. Grygoruk Dnipropetrovsk Regional Clinical Hospital named after I.I. Mechnikov
  • E.A. Gavva Dnipropetrovsk Regional Clinical Hospital named after I.I. Mechnikov
  • A.N. Tolubaiev Dnipropetrovsk Regional Clinical Hospital named after I.I. Mechnikov
Keywords: Ehlers–Danlos syndrome, vertebral arteries, dissection damage, stenosis, aneurysm, endovascular treatment, aneurysm embolization, stenting


A case of treatment of a patient with type 4 of Ehlers–Danlos syndrome and bilateral dissection stenoses and aneurysms in V3and V4-segments of vertebral arteries is described. Also another vascular anomaly was verified: the aberrant right subclavian artery (arteria lusoria). Сerebral angiography with dynamic rotation of the neck revealed a bow hunter's syndrom, which consists in the restriction of blood flow in the right vertebral artery when the head is turned to the left. Stage-by-stage endovascular reconstruction of both vertebral arteries was performed. Firstly, LVIS stent was implanted in the left vertebral artery on the level of the dissection lesion. Then, the aneurysm of the left vertebral artery was embolized by detachable coils. Balloon angioplasty was performed in the stented segment with the compliance balloon-catheter Scepter. On the series of angiograms: the aneurysm is totally excluded, the stenosis of the artery is eliminated. After 1 month, the second stage of endovascular treatment in the same volume in the right vertebral artery was performed. At attempts of a hemostasis with the vascular closure device Аngioseal were unsuccessful in both operations. Hemostasis was successfully performed by manual compression of the puncture site. A mutation in the gene COL3A1, responsible for the synthesis of procollagen III type, was confirmed by Ehlers–Danlos syndrome of type 4 (vascular type) at the subsequent genotyping of the patient. The patient's neurological symptoms regressed to a great extent.

Endovascular methods can be effective in the treatment of vertebral arteries dissection lesions in patients with vascular type of Ehlers–Danlos syndrome.


Download data is not yet available.


Bergqvist D. Ehlers–Danlos type IV syndrome (a review from a vascular surgical point of view). Eur. J. Surg. 1996;162:163-70.

Layman DL, Epstein EH Jr., Dodson RF et al. Biosynthesis of type I and III collagens by cultured smooth muscle cells from human aorta. Proc. Natl. Acad. Sci. 1977;74(2):671-5. DOI:10.1073/ pnas.74.2.671 PMID:322138.

Taylor W, Vandergriff C, Opatowsky M, Layton K. Bowhunter's syndrome diagnosed with provocative digital subtraction cerebral angiography. Proc. Bayl. Univ. Med. Cent. 2012;25(1):26-7.

Schievink WI, Limburg M, Oorthuys JW et al. Cerebrovascular disease in Ehlers–Danlos syndrome type IV. Stroke. 1990;21:626-32. DOI:10.1161/01. STR.21.4.626 PMID:2326845.

Cikrit DF, Miles JH, Silver D. Spontaneous arterial perforation (the Ehlers–Danlos specter). J. Vasc. Surg. 1987; 5:248-55.

Pepin M, Schwarze U, Superti-Furga A et al. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N. Engl. J. Med. 2000;342:67380. DOI:10.1056/NEJM200003093421001 PMID:10706896.

Byers PH, Holbrook KA, McGillivray B et al. Clinical and ultrastructural heterogeneity of type IV Ehlers– Danlos syndrome. Hum. Genet. 1979;47(2):141-50. DOI:10.1007/bf00273196 PMID:437782.

Pope FM, Nicholls AC, Jones PM et al. EDS IV (acrogeria): new autosomal dominant and recessive types. J. R. Soc. Med.1980;73(3):180-6. PMID:7230200.

Lauwers GL, Nevelsteen A, Daenen G et al. Ehlers– Danlos syndrome type IV (a heterogenous disease). Ann. Vasc. Surg. 1997;11:178-82.

Sugiu K, Agari T, Tokunaga K et al. Endovascular treatment for bow hunter's syndrome: case report. Minim. Invasive Neurosurg. 2009;52(4):193-5. doi: 10.1055/s-0029-1239501. Epub 2009 Oct 16.

Freeman KF, Swegle J, Sise MJ. The surgical complications of Ehlers–Danlos syndrome. Am. Surg. 1996;62:869-73.

Germain DP. Ehlers-Danlos syndrome type IV. Orphanet J. Rare Dis. 2007;2:32. DOI:10.1186/17501172-2-32 PMID:17640391.

Germain DP, Herrera-Guzman Y. Vascular Ehlers– Danlos syndrome. J. Ann. Genet. 2004;47:1-9. DOI:10.1016/j.anngen.2003.07.002 PMID:15127738.

Emanuel BS, Cannizzaro LA, Seyer JM et al. Human α1 (III) and α2 (V) procollagen genes are located on the long arm of chromosome 2. Proc. Natl. Acad. Sci. 1985;82: 3385-89. DOI:10.1073/ pnas.82.10.3385 PMID:3858826.

Beighton P, De Paepe A, Danks D et al. International nosology of heritable disorders of connective tissue, Berlin, 1986. Am. J. Med. Genet. 1988;29:581-94. DOI:10.1002/ajmg.1320290316 PMID:3287925.

Pope FM, Martin GR, Lichtenstein JR et al. Patients with Ehlers–Danlos syndrome type IV lack type III collagen. Proc. Natl. Acad. Sci. 1975;72:1314-6. DOI:10.1073/pnas.72.4.1314 PMID:1055406.

Karkos CD, Prasad V, Mukhopadhyay U et al. Rupture of the abdominal aorta in patients with Ehlers–Danlos syndrome. Ann. Vasc. Surg. 2000;14:274-7.

Schwarze U, Goldstein JA, Byers PH. Splicing defects in the COL3A1 gene: marked preference for 5’ (donor) spice-site mutations in patients with exon-skipping mutations and Ehlers-Danlos syndrome type IV. Am. J. Hum. Genet. 1997;61:1276-86. DOI:10.1086/301641 PMID:9399899.

Fox R, Pope FM, Narcisi I.P et al. Spontaneous carotid cavernous fistula in Ehlers–Danlos syndrome. J. Neur. Neuros. Psych. 1988;51:984-6. DOI:10.1136/ jnnp.51.7.984 PMID:3204406.

Pepin MG, Schwarze U, Rice KM et al. Survival is affected by mutation type and molecular mechanism in vascular Ehlers–Danlos syndrome (EDS type IV). Genet. Med. 2014;16:881-8. DOI:10.1038/ gim.2014.72 PMID:24922459.

Oderich G, Panneton J, Bower Lindor N et al. The spectrum, management and clinical outcome of Ehlers–Danlos syndrome type IV: A 30-year experience. J. Vasc. Surg. 2005;42(1):98-106. DOI: https:// doi.org/10.1016/j.jvs.2005.03.053

Liu X, Wu H, Byrne M et al. Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development (gene targetingy Ehlers–Danlos syndrome type IV aortic rupture). Proc. Natl. Acad. Sci. 1997;94:1852-6. DOI:10.1073/pnas.94.5.1852 PM ID:9050868.

Hunter GC, Malone JM, Moore WS et al. Vascular manifestations in patients with Ehlers–Danlos syndrome. Arch Surg. 1982;117:495-8.

How to Cite
Cherednychenko, Y., Miroshnychenko, A., Dzyak, L., Zorin, N., Grygoruk, S., Gavva, E., & Tolubaiev, A. (2018). Endovascular treatment of the patient with vascular type of Ehlers–Danlos syndrome with bilateral dissection stenoses and aneurysms in V3- andV4- segments of vertebral arteries. Ukrainian Interventional Neuroradiology and Surgery, 24(2), 87-96. https://doi.org/10.26683/2304-9359-2018-2(24)-87-96